Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.55 |
| ▸ | LMNA | P02545 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.54 |
| ▸ | PPARA | Q07869 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Etofibrate SCHEMBL8168409 | 1.00 | L3MBTL1 (0.55) | L3MBTL1KMT2ALMNAALDH1A1MEN1 | |
| Etofibrate SCHEMBL29801484 | 1.00 | L3MBTL1 (0.55) | L3MBTL1KMT2ALMNAALDH1A1MEN1 | |
| Etofibrate SCHEMBL1649349 | 0.99 | L3MBTL1 (0.54) | L3MBTL1KMT2ALMNAALDH1A1MEN1 | |
| Ronifibrate SCHEMBL48852 | 0.96 | L3MBTL1 (0.59) | L3MBTL1KMT2ALMNAALDH1A1MEN1 | |
| Simfibrate SCHEMBL5808862 | 0.96 | L3MBTL1 (0.59) | L3MBTL1KMT2ALMNAALDH1A1MEN1 | |
| SCHEMBL10973734 | 0.92 | L3MBTL1 (0.55) | L3MBTL1KMT2ALMNAALDH1A1MEN1 | |
| Picafibrate SCHEMBL2109083 | 0.85 | SMN1; SMN2 (0.65) | KMT2ALMNAALDH1A1MEN1USP2 | |
| Binifibrate SCHEMBL49116 | 0.85 | KMT2A (0.51) | L3MBTL1KMT2ALMNAALDH1A1MEN1 | |
| Binifibrate SCHEMBL29388376 | 0.85 | KMT2A (0.51) | L3MBTL1KMT2ALMNAALDH1A1MEN1 | |
| SCHEMBL2615470 | 0.84 | L3MBTL1 (0.59) | L3MBTL1KMT2ALMNAALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5654 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20240398789-A1 | PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTI-TUMOR EFFECT OF EZH2 INHIBITOR AND USE THEREOF | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2024-12-05 | — | — | US | claimed |
| CN-118236501-A | A composition containing PPARα agonist and folic acid substances | 深圳奥萨医药有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-116568802-A | In vitro method for preparing mature red blood cells | 西湖生物医药科技(上海)有限公司 | 2023-08-08 | — | — | CN | claimed |
| WO-2023061446-A1 | PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTI-TUMOR EFFECT OF EZH2 INHIBITOR, AND USE THEREOF | 北京大学第三医院（北京大学第三临床医学院） | 2023-04-20 | — | — | WO | claimed |
| EP-4165233-A1 | HYBRID ELECTRODIALYSIS AND ELECTROLYSIS SYSTEMS AND PROCESSES | Pani Clean, Inc. (US) | 2023-04-19 | — | — | EP | claimed |
| US-20230059619-A1 | SOLID DISPERSIONS | INTERNATIONAL N&H USA, INC. | 2023-02-23 | — | — | US | claimed |
| CN-115364231-A | Pharmaceutical composition for enhancing anti-tumor effect of EZH2 inhibitor and application thereof | 北京大学第三医院（北京大学第三临床医学院） | 2022-11-22 | — | — | CN | claimed |
| US-11504324-B2 | Nanosuspension formulation | DuPont Nutrition USA, Inc. (US) | 2022-11-22 | — | — | US | claimed |
| US-11369575-B2 | PPARα agonist compositions and methods of use | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2022-06-28 | — | — | US | claimed |
| WO-1997037629-A1 | PROCESS FOR ENCAPSULATION OF CAPLETS IN A CAPSULE AND SOLID DOSAGE FORMS OBTAINABLE BY SUCH PROCESS | WARNER-LAMBERT COMPANY (US) | 1997-10-16 | — | — | WO | claimed |
| EP-0525389-B1 | Process for preparing mechanically stable, well disintegrating tablets from small active agent containing solid forms | MERZ & CO GMBH & CO (DE) | 1996-05-22 | — | — | EP | claimed |
| EP-0469328-B1 | Process for the preparation of small controlled release particles with a high content of Etofibrat, its use and its orally administrable forms | MERZ & CO GMBH & CO (DE) | 1994-06-01 | — | — | EP | claimed |
| EP-0468247-B1 | Process for the preparation of tablets mechanically stable and well-disintegrable, from small extrusion pellets with a high etofibrat content | MERZ & CO GMBH & CO (DE) | 1994-06-01 | — | — | EP | claimed |
| EP-0168360-B1 | PROCESS FOR PREPARING ETOFIBRATE OR SIMILAR COMPOUNDS CONTAINING SUSTAINED RELEASE MICROGRANULES AND PRODUCTS THUS OBTAINED | Valducci, Roberto (IT) | 1992-06-10 | — | — | EP | claimed |
| US-4957746-A | Process for preparing etofibrate or similar compounds containing sustained release microgranules and products thus obtained | VALDUCCI ROBERTO (IT) | 1990-09-18 | — | — | US | claimed |
| EP-0168360-A2 | Process for preparing etofibrate or similar compounds containing sustained release microgranules and products thus obtained | Valducci, Roberto (IT) | 1986-01-15 | — | — | EP | claimed |
| US-4250191-A | ADMINISTERING A PHENOXYACETIC ACID DERIVATIVE | EDWARDS K DAVID | 1981-02-10 | — | — | US | claimed |
| US-4028369-A | Preparation of glycol (2-(p-chlorophenoxy)-2-methylpropionate)-2-nicotinate | ALTER S.A. (ES) | 1977-06-07 | — | — | US | claimed |
| US-4017502-A | Process for purifying the mixed ester, ethylene glycol 1-(2-p-chlorophenoxy)-2-methylpropionate nicotinate | ALTER, S.A. (ES) | 1977-04-12 | — | — | US | claimed |